Figure 1 (Tramadol 02)
Tramadol Hydrochloride
Product Images NDC 67296-1919
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 67296-1919). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Tramadol 03)
This is a graph showing the percentage of participants discontinuing a specific protocol (CAPSS-047) over time due to nausea or vomiting. The data suggests that there was an increase in discontinuation rates up to 40% within the first 10 days of the study, with a peak of 50% discontinuation by day 15. The study lasted at least 25 days in a double-blind setting.*
Structure (Tramadol 1)
Image Description (Tramadol Label 50mg 1000s)
This text appears to be a medication label providing information about Tramadol hydrochloride tablets USP. It includes instructions to store the tablets in a controlled environment at room temperature, dispense in a tight container as defined in the US Pharmacopeia (USP), and keep all medications out of the reach of children. It also mentions the quantity of tablets (1000 tablets) and the active ingredient content (50mg Tramadol hydrochloride per tablet). Additionally, it advises pharmacists to dispense the Medication Guide separately to each patient. The label features details such as NDC number and manufacturer information.*
Image Description (Tramadol Label 50mg 100s)
Image Description (Tramadol Label 50mg 500s)
This is a label for Tramadol hydrochloride tablets USP, containing 500 tablets with a strength of 50 mg each. It provides storage instructions and advises keeping the medication away from children. The manufacturer is Elysium Pharmaceuticals Limited, located in Vadodara, India, and the distributor is A Healthcare USA Inc. in Coral Springs, Florida. The label also includes a revision date of 02/2022 and a space for batch details.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
